True North Therapeutics Receives FDA Orphan Drug Designation for TNT009 for the Treatment of Autoimmune Hemolytic Anemia, Including Cold Agglutinin Disease (CAD) South San Francisco, CA, October 13, 2016 — True North Therapeutics, a clinical stage biotechnology...
TigerText Earns Prestigious HITRUST CSF Certification 3rd-party certification from U.S. healthcare industry’s premier security testing agency confirms TigerText’s place as the most trusted name in healthcare communications SANTA MONICA, Calif. (July 27, 2016) –...
Aptuit LLC and Dimension Therapeutics Enter Strategic Partnership to Advance Select Dimension Programs Toward IND Filing GREENWICH, Connecticut and CAMBRIDGE, Massachusetts, July 7, 2016 /PRNewswire/ — Aptuit LLC, a premier global drug discovery and development...
Merck to Acquire Afferent Pharmaceuticals KENILWORTH, N.J. & SAN MATEO, Calif., June 9, 2016 – Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Afferent Pharmaceuticals announced today that the two companies have signed a definitive...
Kit Check Tracks 10 Million Hospital Medications to Become Largest Scale IoT and Cloud Software Solution in Healthcare by Ava Mutchler March 17 2016, WASHINGTON – Kit Check™ (http://kitcheck.com), the leader in hospital pharmacy kit restocking automation and...
RELYPSA ANNOUNCES FDA APPROVAL OF VELTASSA(TM) (PATIROMER) FOR ORAL SUSPENSION FOR THE TREATMENT OF HYPERKALEMIA First new medicine for the treatment of hyperkalemia, or high blood potassium levels, in more than 50 years Approximately 3 million people with chronic...
Recent Comments